Rafferty Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.08M Sell
95,716
-8,983
-9% -$195K 0.01% 603
2025
Q1
$2.54M Sell
104,699
-12,393
-11% -$301K 0.01% 514
2024
Q4
$2.44M Sell
117,092
-5,398
-4% -$113K 0.01% 586
2024
Q3
$2.44M Sell
122,490
-63,004
-34% -$1.25M 0.01% 581
2024
Q2
$2.87M Sell
185,494
-301,280
-62% -$4.67M 0.01% 540
2024
Q1
$7.76M Buy
486,774
+134,612
+38% +$2.15M 0.03% 357
2023
Q4
$5.92M Sell
352,162
-158,273
-31% -$2.66M 0.03% 404
2023
Q3
$5.97M Sell
510,435
-204,440
-29% -$2.39M 0.04% 353
2023
Q2
$9.61M Buy
714,875
+250,208
+54% +$3.36M 0.05% 218
2023
Q1
$7.7M Sell
464,667
-27,784
-6% -$461K 0.05% 254
2022
Q4
$9.16M Buy
492,451
+87,742
+22% +$1.63M 0.08% 200
2022
Q3
$5.19M Buy
404,709
+218,609
+117% +$2.8M 0.06% 330
2022
Q2
$1.31M Sell
186,100
-45,408
-20% -$318K 0.01% 570
2022
Q1
$1.92M Buy
231,508
+2,920
+1% +$24.2K 0.01% 614
2021
Q4
$1.55M Buy
228,588
+35,802
+19% +$242K 0.01% 746
2021
Q3
$1.02M Buy
192,786
+594
+0.3% +$3.15K 0.01% 808
2021
Q2
$1.11M Sell
192,192
-243,632
-56% -$1.4M 0.01% 846
2021
Q1
$2.01M Buy
435,824
+375,238
+619% +$1.73M 0.01% 627
2020
Q4
$202K Sell
60,586
-172,744
-74% -$576K ﹤0.01% 990
2020
Q3
$693K Buy
233,330
+148,429
+175% +$441K 0.01% 633
2020
Q2
$392K Buy
84,901
+50,853
+149% +$235K 0.01% 767
2020
Q1
$131K Sell
34,048
-328,248
-91% -$1.26M 0.01% 550
2019
Q4
$1.36M Buy
362,296
+192,878
+114% +$724K 0.02% 476
2019
Q3
$900K Buy
+169,418
New +$900K 0.01% 565